Tech Company Financing Transactions
ZetaRx Biosciences Funding Round
Private investors participated in a $2 million capital raise for ZetaRx Biosciences. The financing round was announced by the company on 12/13/2012.
Transaction Overview
Company Name
Announced On
12/13/2012
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Not a solicitation.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
307 Westlake Ave. North 300
Seattle, WA 98109
USA
Seattle, WA 98109
USA
Phone
Email Address
Not Recorded
Overview
The company operates as a biotechnology company.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Executive Vice President
Cynthia Shumate
Browse more venture capital transactions:
Prev: 12/13/2012: WSO2 venture capital transaction
Next: 12/13/2012: CloudVelox venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. All VC database entries on this site are derived from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs